Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

ALLERGENE

Financiado

Allergic multimorbidity from birth to young adulthood determinants epigenetic...

Allergic multimorbidity from birth to young adulthood determinants epigenetic regulation and inflammatory processes The prevalence of allergic diseases, such as atopic eczema, asthma and rhinitis, has increased over the past decades and is currently estimated to be up to 40%. Prevention strategies play a pivotal role, as there are no curative t... ver más

28/02/2026

HMGU

1M€

Presupuesto del proyecto: 1M€

Líder del proyecto

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 2 Participantes

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-12-11

ERC-2020-STG: ERC STARTING GRANTS

I+D

Cerrada hace 5 años

0% 100% 100%

2 Participantes

HMGU

1.49M€ | Lider

FELGUERA CONSTRUCCIONES MECA...

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

AGL2008-04124 IMPORTANCIA DE LA DIETA DURANTE LA PRIMERA ETAPA DE LA VIDA... 30K€ Cerrado

PID2020-116274RB-I00 ENFOQUE OMICO INTEGRADOR PARA EVALUAR EL PAPEL DE LA METILAC... 145K€ Cerrado

AGL2009-09730 IMPORTANCIA DE LOS ACIDOS GRASOS DURANTE LA PRIMERA ETAPA DE... 121K€ Cerrado

BIO2017-84548-R ESTUDIO DEL PAPEL DE LOS LIGANDOS LIPIDICOS TRANSPORTADOS PO... 121K€ Cerrado

PID2020-116692RB-I00 ALERGENOS Y EJE INTESTINO-PULMON: NUEVAS APROXIMACIONES AL D... 237K€ Cerrado

CAMERA Causes and MEchanisms foR non atopic Asthma in children 3M€ Cerrado

Duración del proyecto: 62 meses Fecha Inicio: 2020-12-11
Fecha Fin: 2026-02-28

Líder del proyecto

HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUN... No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 1M€

Descripción del proyecto The prevalence of allergic diseases, such as atopic eczema, asthma and rhinitis, has increased over the past decades and is currently estimated to be up to 40%. Prevention strategies play a pivotal role, as there are no curative treatments available. Therefore, the aim of ALLERGENE is to understand the complex interplay of genetic, environmental and lifestyle factors and to identify involved mechanisms that distinguish between young adults free of allergic diseases and those suffering from allergic multimorbidity. Therefore, the aims of the present project are to: 1. Define allergic disease trajectories from birth to young adulthood, describe their determinants and identify risk and protective early-life environmental and lifestyle factors contributing to progression towards allergic multimorbidity or remission of allergic diseases. 2. Investigate molecular mechanisms of epigenetic regulation of allergic disease trajectories and test effect modification by inclusion of selected environmental and lifestyle factors. 3. Characterise the underlying inflammation profile of allergic disease trajectories and determine interactions with environmental and lifestyle factors The project makes use of two long-standing, prospective German birth cohort studies, GINIplus and LISA, with available data from birth to young adulthood, and an extensive examination planned at age 25. Within this project, a comprehensive characterisation of allergic disease trajectories, their determinants, comorbidities, risk and protective factors across the life-course will be obtained. ALLERGENE will enhance the understanding of how modifiable factors contribute to allergic disease aetiology. This will be an essential prerequisite to develop effective early intervention strategies for susceptible populations and to identify disease-specific biomarkers for the development and progression of allergic diseases in the future.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores